Temsirolimus with BERT for the treatment of relapsed mantle cell and follicular lymphoma
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
Results of KEYNOTE-023 and pembrolizumab plus pomalidomide trials for multiple myeloma
Jesús San Miguel
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Measuring treatment response rates in multiple myeloma